Gaudium IVF and Women Health Limited announced its unaudited financial results for Q2 and H1 FY27. Revenue from operations for Q2 FY27 grew by 17.9% YoY to ₹37.4 crore. This growth was supported by increased patient volumes and the initial contribution from two new IVF hubs launched in South Extension, New Delhi, and Gurgaon, Haryana, as part of its 19-centre expansion plan. Despite one-off expenses related to new hubs, PAT saw a marginal increase of 0.4% YoY to ₹9.4 crore.
Gaudium IVF Reports Strong Q2 FY27 Performance
Gaudium IVF and Women Health Limited has announced its unaudited financial results for the second quarter and the half-year ended September 30, 2026. The company reported a robust year-on-year revenue growth of 17.9% in Q2 FY27, reaching ₹37.4 crore. This increase was attributed to stronger patient volumes in its mature centers and the commencement of operations at its new IVF hubs in South Extension, New Delhi, and Gurgaon, Haryana. These openings mark significant milestones in the company’s planned 19-centre expansion.
Financial Highlights for Q2 FY27
For the second quarter of FY27, Gaudium IVF’s revenue from operations stood at ₹37.4 crore, a substantial increase from ₹31.7 crore in the corresponding period last year. EBITDA was reported at ₹13.5 crore, with an EBITDA margin of 36.0%. The company noted that this quarter absorbed one-off rollout expenses for the two new hubs and accounted for the higher fixed-cost base during their initial ramp-up phase. Profit After Tax (PAT) was ₹9.4 crore, marking a modest 0.4% growth YoY, with a PAT margin of 25.2%.
Half-Yearly Performance (H1 FY27)
In the first half of FY27, consolidated revenue reached ₹56.8 crore, up 14.7% compared to H1 FY26. EBITDA for H1 FY27 was ₹15.9 crore, with a margin of 28.0%. PAT for the half-year stood at ₹11.2 crore, with a margin of 19.7%.
Key Operational Expansions
The company successfully commenced commercial operations at its South Extension hub in New Delhi on July 16, 2026. This center features the Gaudium Signature Lab, equipped with Al-powered embryology tools. Following this, the Gurgaon hub in Haryana began operations on September 24, 2026, also built on the Gaudium Signature Lab framework. These are the first two new hubs launched under the company’s IPO expansion program.
Future Outlook
Dr. Manika Khanna, Chairperson and Managing Director, expressed optimism about the company’s trajectory. She highlighted that while the initial phase of new hubs involves higher fixed costs, operating leverage is expected to improve as patient volumes grow. Historically, the second half of the financial year contributes more to annual revenue, and with ongoing expansion and mature hubs growing, Gaudium IVF anticipates a stronger second half of FY27.
Key Metrics
As of September 30, 2026, Gaudium IVF operates a network of 9 hubs and 28 spokes across India, maintaining a clinical pregnancy success rate of 62% on the first IVF attempt.
Source: BSE
